Assisted Saliva Collection Kits (GFXA Series)
€35.00 – €683.00Price range: €35.00 through €683.00
GeneFix assisted saliva collectors provide reliable DNA/RNA stabilization for individuals unable to self-collect using a funnel, e.g. small children, the elderly, or patients with physical limitations. Swab-style collection with pre-filled buffer tube for secure, room-temperature storage.
Available in 2x, 12x and 50x pack sizes
€
-
€
-
kr.
-
kr
-
kr
-
kr.
Description
GeneFix® Assisted Saliva DNA/RNA Collector – GFXA Series
The GeneFix Assisted Saliva Collector (GFXA) is a specially designed device for DNA and RNA stabilization in situations where standard funnel-based saliva collection is not possible. This includes infants, elderly individuals, or patients with medical or physical limitations.
Key Features:
- Assisted saliva collection for DNA and RNA stabilization
- Swab-style sampling with easy-to-use applicator
- Pre-filled stabilization buffer tube
- Sample stability for DNA (up to 5 years at room temperature)
- Ideal for pediatric, geriatric, and care-based settings
- Compatible with standard extraction and downstream workflows
- CE-marked and ISO 9001 compliant
Applications:
- DNA and RNA sampling in assisted-care environments
- At-home or clinical genetic testing
- Biobanking and research with hard-to-sample populations
- Public health, infectious disease studies
- Newborn or geriatric screening programs
Benefits:
- Enables sample collection where self-sampling is difficult
- Maintains sample integrity without cold chain
- Fully compatible with GeneFix and Isohelix lab workflows
- Intuitive and hygienic for caregiver-assisted use
Each kit contains:
- Saliva collection tube pre-filled with stabilization buffer
- Assisted collection swab and user guide
Download GeneFix Brochure (PDF)
References
- The Association of Parental Genetic, Lifestyle, and Social Determinants of Health with Offspring Overweight. Lifestyle Genomics 2020.
- Genetic associations with measles PRNT and IgG antibody response to MMR vaccination in 6- and 15-month-old children. Vaccine, 2025




